Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis – 2020 update

Fernandes BM; Guimarães F; Almeida DE; Neto A; Tavares-Costa J; Ribeiro AR; Quintal A; Pereira JP; Silva L; Nóvoa TSd; Faustino A; Vaz C; Khmelinskii N; Samões B; Dourado E; Silva JL; Barcelos A; Mariz E; Guerra M; Santos MJ; Silvério-António M; Teixeira RL; Romão VC; Santos H; Santos-Faria D; Azevedo S; Rodrigues A; Dias JM; Lopes C; Pinto P; Couto M; Miranda LC; Bernardo A; Cruz M; Teixeira F; Mourão AF; Neto A; Teixeira V; Cordeiro A; Barreira S; Inês LS; Capela S; Sepriano A; Canhão H; Fonseca JE; Duarte C; Bernardes M;